Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H16ClNO3 |
| Molecular Weight | 305.756 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC2=C(C=C1O)C(COC3=CC=C(Cl)C=C3)NCC2
InChI
InChIKey=GVALVWDQPXGPCE-UHFFFAOYSA-N
InChI=1S/C16H16ClNO3/c17-11-1-3-12(4-2-11)21-9-14-13-8-16(20)15(19)7-10(13)5-6-18-14/h1-4,7-8,14,18-20H,5-6,9H2
| Molecular Formula | C16H16ClNO3 |
| Molecular Weight | 305.756 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Clofeverine is a compound synthesized by the Japanese company Fujisawa Pharmaceutical. Clofeverine is a highly selective relaxant for gastrointestinal smooth muscles with a beta-receptor stimulative nature. On isolated ileum, the inhibitory effect of clofeverine for spontaneous motility was comparable to that of isoproterenol and 100 times higher than that of papaverine.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 06:52:42 GMT 2025
by
admin
on
Wed Apr 02 06:52:42 GMT 2025
|
| Record UNII |
584A0O55XM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66880
Created by
admin on Wed Apr 02 06:52:42 GMT 2025 , Edited by admin on Wed Apr 02 06:52:42 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
584A0O55XM
Created by
admin on Wed Apr 02 06:52:42 GMT 2025 , Edited by admin on Wed Apr 02 06:52:42 GMT 2025
|
PRIMARY | |||
|
C77986
Created by
admin on Wed Apr 02 06:52:42 GMT 2025 , Edited by admin on Wed Apr 02 06:52:42 GMT 2025
|
PRIMARY | |||
|
100000084313
Created by
admin on Wed Apr 02 06:52:42 GMT 2025 , Edited by admin on Wed Apr 02 06:52:42 GMT 2025
|
PRIMARY | |||
|
3531
Created by
admin on Wed Apr 02 06:52:42 GMT 2025 , Edited by admin on Wed Apr 02 06:52:42 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106010
Created by
admin on Wed Apr 02 06:52:42 GMT 2025 , Edited by admin on Wed Apr 02 06:52:42 GMT 2025
|
PRIMARY | |||
|
194700
Created by
admin on Wed Apr 02 06:52:42 GMT 2025 , Edited by admin on Wed Apr 02 06:52:42 GMT 2025
|
PRIMARY | |||
|
DTXSID70969433
Created by
admin on Wed Apr 02 06:52:42 GMT 2025 , Edited by admin on Wed Apr 02 06:52:42 GMT 2025
|
PRIMARY | |||
|
54340-63-5
Created by
admin on Wed Apr 02 06:52:42 GMT 2025 , Edited by admin on Wed Apr 02 06:52:42 GMT 2025
|
PRIMARY | |||
|
SUB06703MIG
Created by
admin on Wed Apr 02 06:52:42 GMT 2025 , Edited by admin on Wed Apr 02 06:52:42 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |